Publications

5674 Results

Correlation of tumor O6 methylguanine-DNA methyltransferase levels with survival for malignant astrocytoma patients treated with bis-chloroethylnitrosourea: A Southwest Oncology Group study.

Authors
KA Jaeckle;HJ Eyre;JJ Townsend;S Schulman;HM Knudson;M Belanich;DB Yarosh;SI Bearman;DJ Giroux;SC Schold
Journal / Conference
Journal of Clinical Oncology 16(10):3310-3315
Year
1998
Research Committee(s)
Brain
Study Number(s)
SWOG-9218

Southwest Oncology Group (SWOG) accrual by sex, race, and age, compared to US population rates.

Authors
J Unger;L Hutchins;J Crowley;C Coltman;K Albain
Journal / Conference
Proc of the American Society of Clinical Oncology 17:414(#1596)
Year
1998

MOPP/ABV hybrid chemotherapy for advanced Hodgkin's disease significantly improves failure-free and overall survival: The 8-year result of the intergroup trial.

Authors
JH Glick;ML Young;D Harrington;RL Schilsky;T Beck;R Neiman;RI Fisher;BA Peterson;MM Oken
Journal / Conference
Journal of Clinical Oncology 16(1):19-26
Year
1998
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8796

Hormone receptor immunoreactivity in hemangioblastomas and clear cell renal cell carcinomas.

Authors
DF Brown;MA Dababo;CL Hladik;KP Eagan;CL White;EJ Rushing
Journal / Conference
Modern Pathology 11(1):55-59
Year
1998
Research Committee(s)
Genitourinary

A phase II Southwest Oncology Group study of dihydroxyazacytidine for mesothelioma.

Authors
LM Bavisotto;C Rankin;BC Behrens;DR Gandara;SE Rivkin;SP Balcerzak;K Antman
Journal / Conference
Cancer Therapeutics 1(1):18-20
Year
1998
Research Committee(s)
Sarcoma
Study Number(s)
SWOG-8842

13-cis-retinoic acid or all-trans-retinoic acid plus interferon-a in recurrent cervical cancer: A Southwest Oncology Group phase II randomized trial.

Authors
GR Weiss;PY Liu;DS Alberts;Y Peng;E Fisher;MJ Xu;SA Scudder;LH Baker;DF Moore Jr;SM Lippman
Journal / Conference
Gynecologic Oncology 71:386-390
Year
1998
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-9132, SWOG-9225

A randomized study of alpha-interferon consolidation in patients with low-grade lymphoma who have responded to pro-MACE-MOPP (day 1-8) (SWOG 8809).

Authors
BW Dana;J Unger;RI Fisher
Journal / Conference
Proc of the American Society of Clinical Oncology 17:3a(#10)
Year
1998
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8809

Chemo-radiotherapy (CT-RT) vs radiotherapy (RT) in patients (pts) with advanced nasopharyngeal cancer (NPC). Intergroup (0099) (SWOG 8892, RTOG 8817, ECOG 2388) phase III study: Progress report.

Authors
M Al-Sarraf;M LeBlanc;PGS Giri;K Fu;J Cooper;T Vuong;A Forastiere;G Adams;W Sakr;D Schuller;J Ensley
Journal / Conference
Proc of the American Society of Clinical Oncology 17:385a(#1483)
Year
1998
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8892 (INT-0099) (EST-2388) (RTOG-8817)

CMF versus CAF with and without tamoxifen in high-risk node-negative breast cancer patients and a natural history follow-up study in low-risk node-negative patients: First results of intergroup trial INT 0102.

Authors
L Hutchins;S Green;P Ravdin;D Lew;S Martino;M Abeloff;A Lyss;C Henderson;C Allred;S Dakhil;I Pierce;W Goodwin;J Caton;S Rivkin;R Chapman;K Osborne
Journal / Conference
Proc of the American Society of Clinical Oncology 17:1a(#2)
Year
1998
Research Committee(s)
Breast
Study Number(s)
SWOG-8897

Phase II trial of oral etoposide in recurrent or refractory endometrial adenocarcinoma (SWOG 9212).

Authors
EA Poplin;PY Liu;J Delmore;S Wilczynski;D Alberts
Journal / Conference
Proc of the American Society of Clinical Oncology 17:373a(#1436)
Year
1998
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-9212